ELAN (STOCKS)
Elanco Animal Health Incorporated Common Stock
$22.530000
+0.400000 (+1.81%)
Prev close: $22.130000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Jeffrey N. Simmons
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $11,243.99M
- Employees
- 9,450
- P/E (TTM)
- -55.65
- P/B (TTM)
- 1.68
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $5.02B |
| Benefits Costs and Expenses | $5.19B |
| Cost Of Revenue | $2.24B |
| Costs And Expenses | $5.19B |
| Gross Profit | $2.78B |
| Operating Expenses | $2.95B |
| Selling, General, and Administrative Expenses | $1.52B |
| Research and Development | $371.00M |
| Other Operating Expenses | $1.06B |
| Operating Income/Loss | -$166.00M |
| Income/Loss From Continuing Operations After Tax | -$199.00M |
| Income/Loss From Continuing Operations Before Tax | -$166.00M |
| Income Tax Expense/Benefit | $33.00M |
| Net Income/Loss | -$199.00M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$199.00M |
| Net Income/Loss Available To Common Stockholders, Basic | -$199.00M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.41 |
| Diluted Earnings Per Share | -$0.41 |
| Basic Average Shares | 1,494,200,000 |
| Diluted Average Shares | 997,900,000 |
| Assets | $13.56B |
| Current Assets | $3.80B |
| Inventory | $1.77B |
| Other Current Assets | $2.03B |
| Noncurrent Assets | $9.76B |
| Fixed Assets | $1.41B |
| Intangible Assets | $3.20B |
| Other Non-current Assets | $5.15B |
| Liabilities | $6.97B |
| Current Liabilities | $1.85B |
| Accounts Payable | $427.00M |
| Other Current Liabilities | $1.43B |
| Noncurrent Liabilities | $5.12B |
| Long-term Debt | $3.66B |
| Other Non-current Liabilities | $1.46B |
| Equity | $6.59B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $6.59B |
| Liabilities And Equity | $13.56B |
| Net Cash Flow From Operating Activities | $617.00M |
| Net Cash Flow From Operating Activities, Continuing | $617.00M |
| Net Cash Flow From Investing Activities | -$335.00M |
| Net Cash Flow From Investing Activities, Continuing | -$335.00M |
| Net Cash Flow From Financing Activities | -$310.00M |
| Net Cash Flow From Financing Activities, Continuing | -$310.00M |
| Exchange Gains/Losses | $19.00M |
| Net Cash Flow | -$9.00M |
| Net Cash Flow, Continuing | -$28.00M |
| Comprehensive Income/Loss | -$226.00M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$226.00M |
| Other Comprehensive Income/Loss | -$191.00M |
| Other Comprehensive Income/Loss Attributable To Parent | -$27.00M |